cell therapy Archives - NeuroNews International

Athersys granted clinical Type B meeting with US FDA to discuss...

17 February 2023

Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with...

Write to us
Editor: Jamie Bell [email protected]
Advertising: Michael Broughton [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy

Tag: cell therapy

Athersys granted clinical Type B meeting with US FDA to discuss...